Feb. 11, 2026
Illustration of cancer cells, with a highlighted tumor cell in the center targeted by a digital crosshair.

Advancing the frontiers of regenerative medicine means more than pushing scientific boundaries — it means improving and extending human life. The Regenerative Engineering and Medicine Center (REM) is a partnership with Georgia Tech, Emory University, and the University of Georgia (UGA) that supports this mission through inter-institutional collaborations in research in regenerative medicine.  

Since 2010, competitive peer-reviewed seed grants have been awarded annually to interdisciplinary teams with representation from at least two of the three institutions, leading to clinical trials, licensed technologies, start-up companies, and external funding for additional research. The Parker H. Petit Institute for Bioengineering and Bioscience (IBB) is excited to announce the 2026 REM Collaborative Seed Grant awardees: Melissa Kemp (Georgia Tech) and Rabindra Tirouvanziam (Emory); Yang Liu (UGA) and Yong Teng (Emory); and Steven Stice (UGA) and Zhexing Wen (Emory). 

Kemp and Tirouvanziam were awarded funding for their proposal, “Predicting Personalized Extracellular Vesicle (EV) Responses for Directed Myeloid‑Targeted Immunotherapy.” Their project combines computer modeling and lab‑grown lung tissue to better understand how immune cells communicate during lung infections and inflammation in different people. This research could help scientists design more precise, patient‑specific therapies for respiratory diseases, potentially improving treatments for conditions ranging from viral infections to chronic inflammation. 

"We are grateful for the support from REM that allows us to extend our labs into new, interdisciplinary research,” Kemp said. “This pilot project will allow us to develop and experimentally validate multicellular models of the lung environment. Our goal is to use our platforms to test potential therapeutics that operate by controlling communication between cell types." 

“It is wonderful to be supported by REM for this collaboration between Georgia Tech and Emory labs,” Tirouvanziam agreed. “We hope to turn this pilot into a large extramural project with a focus on novel immunotherapy.” 

Liu and Teng were awarded funding for their proposal, “AI‑Guided Profiling of Migratory Cancer Stem Cell Communication in Head and Neck Cancer.”  Their project aims to uncover how the most aggressive cancer stem cells move and “talk” to nearby immune and tissue cells, using advanced microfluidic tools and artificial intelligence to study how these cells help cancer spread and resist treatment.  Understanding these hidden communication pathways could lead to earlier detection of dangerous cancer cell types and inspire new therapies that prevent recurrence and improve survival for patients with head and neck cancer. 

“We combine microfluidic tools with artificial intelligence to monitor individual cancer cells in action and study how they interact with the immune microenvironment — capturing behaviors that are missed in bulk experiments and shedding light on how aggressive cancer cells escape therapy,” Liu said of the project.  

Stice and Wen were awarded funding for their application, “Use of Alzheimer’s Disease Organoids to Assess Mesenchymal Stromal Cell–Derived Extracellular Vesicles Mechanism of Action.”  Their project uses lab‑grown human brain organoids to study how tiny therapeutic particles called extracellular vesicles that are released by stem cells might reduce brain inflammation and protect neurons affected by Alzheimer’s disease.  Revealing how these vesicles work at a molecular level could help advance new treatments that go beyond symptom management and move toward slowing or preventing Alzheimer’s progression. 

“Extracellular vesicles (EVs) are used in the body to communicate with cells around an injury and are known to repair brain tissue in Alzheimer’s animal models,” Stice said.  “Understanding the signaling mechanisms used by EVs in Alzheimer’s brain organoids will directly lead to better EV manufacturing processes and potency for neurodegenerative diseases, and ultimately better therapies.” 

This year’s funded work illustrates how collaboration across institutions accelerates discoveries. Together, these teams are pushing healing technologies closer to real‑world impact, where they can make a tangible difference for patients affected by serious illness. 

News Contact

Ashlie Bowman | Communications Program Manager

Parker H. Petit Institute for Bioengineering and Bioscience

Feb. 18, 2026
Lynn Kamerlin headshot

School of Chemistry and Biochemistry Professor and Georgia Research Alliance Vasser Woolley Chair in Molecular Design Lynn Kamerlin has become an Institute of Physics (IOP) Fellow. It is the highest degree of membership awarded by the society.

"The IOP has a long and distinguished history as the primary learned society and professional body for physicists in the U.K., Ireland, and beyond,” says Kamerlin, who completed both a Master of Natural Sciences and a Ph.D. in Theoretical Organic Chemistry from the University of Birmingham in the United Kingdom. “As a society, it plays an important role in building community, promoting science, advancing advocacy for our discipline, and supporting the next generation of physicists.”

Kamerlin joins a list of distinguished Fellows that includes legendary physicists such as Dame Jocelyn Bell Burnell, a preeminent astrophysicist responsible for the discovery of pulsars (a previously unknown type of star) and the first female president of the IOP.

“It is a great honor to be awarded Fellowship of the IOP, particularly as women more broadly remain vastly underrepresented in physics,” Kamerlin says. “I look forward to giving back to the physics community, supporting the mission of the society, and working to remind the next generation that physics is for everyone."

About Lynn Kamerlin

Kamerlin’s research in computational biophysics is at the intersection of chemistry and biology, where she focuses on investigating fundamental physical chemistry and using computational tools to understand complex biomolecular problems. Currently, she is interested in leveraging machine learning tools to design new enzymes and in predicting protein structures and behaviors using large language models.

In addition to her roles at Georgia Tech, Kamerlin is a senior editor of Protein Science, the editor-in-chief of Electronic Structure, and was named a 2025-27 visiting professor at Lund University. She was also named a Fellow of the Royal Society of Chemistry, received the 2026 Inspiration and Resilience Award from the Biochemical Society, and was the 2023 Biophysical Society Theory & Computation Subgroup Mid-Career Award Winner.

News Contact

Written by Selena Langner

Feb. 06, 2026
Leanne West

Leanne West, chief engineer of pediatric technologies at Georgia Tech and a national leader in pediatric health innovation, has been honored as a 2026 Innovator of the Year in Pediatric Health by the Atlanta Business Chronicle and selected as one of Titan CEO’s 2026 Georgia Titan 100 Honorees. These recognitions celebrate West’s leadership and impact in pediatric health innovation at both the local and national level. In January, West was also named chief research and innovation officer at Shriners Children’s, a role that expands her longstanding commitment to pediatric innovation. 

For more than a decade, West has been instrumental in the partnership between Georgia Tech and Children’s Healthcare of Atlanta, working through the Pediatric Technology Center (PTC) to translate clinical needs into engineered solutions for children. In this role, she has worked alongside Children’s clinicians, nurses, and researchers to identify unmet needs, form multidisciplinary teams, and guide projects from early concepts through prototyping, validation, funding, and regulatory pathways. The Children’s Healthcare of Atlanta PTC established Atlanta as a nationally recognized hub for pediatric technology innovation enabling clinician-driven research, accelerating translational projects, and fostering a culture in which engineering solutions are shaped directly by real clinical experience. 

In 2019, West began building a relationship with Shriners, working to understand their most pressing clinical needs. She then connected clinicians with researchers at Georgia Tech, Emory University, and Kennesaw State University to foster collaborations focused on real-world clinical challenges. She also supported teams with promising prototypes by helping them navigate national funding opportunities and pathways at the Federal Drug Administration (FDA), accelerating the transition from lab discoveries to patient care.  

Over time, this steady engagement evolved into a strong research partnership. In June 2025, Shriners announced they are joining the robust pediatric innovation ecosystem in Atlanta by establishing the Shriners Children’s Research Institute (SCRI). SCRI will be co-located with Georgia Tech as the anchor tenant at Science Square. This investment will be transformational for the future of pediatric research and innovation in the state of Georgia. 

“What excites me most is what we can accomplish together when we combine our strengths to align around a children-first mindset to improve the healthcare of children everywhere,” said West. “Kids will benefit in ways no one organization could achieve alone.” 

West’s leadership in pediatric innovation doesn’t stop there. In November 2025, she consolidated three major gatherings into the first International Pediatric Healthcare Innovation Summit, combining the Pediatric Innovation Day, the International Society for Pediatric Innovation’s (iSPI) biennial PEDS2040 event, and the joint meeting of the FDA-funded Pediatric Device Consortia. The Summit highlighted the work of Children’s Healthcare of Atlanta, bringing together more than 150 representatives from children’s hospitals, startups, venture capitalists, clinicians, patients, and leaders from across the Georgia innovation ecosystem, strengthening the region’s global presence in pediatric health innovation. 

As president of the International Children’s Advisory Network (iCAN), West continues to elevate the voices of young people with chronic and rare conditions and their caregivers. Under her leadership, iCAN partners with industry, regulators, and the FDA to ensure pediatric patients are included in device and drug development, clinical trials, healthcare education, and regulatory conversations. She also champions opportunities that train and inspire youth and early career professionals to pursue roles across healthcare and life sciences — from clinicians and innovators to public health leaders and patient advocates. 

West served as an invited speaker at the 2025 World Health Organization’s World Children’s Health Day on the Importance of Clinical Trials for the Safety of Children, and at the FDA’s meeting on the Implementation of the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act. She continues to contribute nationally through service on the Medical Device Innovation Consortium’s (MDIC) NEST executive committee to advance use of real-world evidence in regulatory submissions, particularly for pediatric devices, and the MDIC Patient Value committee. In addition, she serves on the iSPI executive team, the Patient Focused Medicines Development board, the Pediatric Trials Network steering committee, and as a judge for MedTech Innovator. 

West’s awards and new role reflect the cumulative impact of more than a decade of leadership, partnership-building, and translational work across the worldwide pediatric ecosystem. West and her fellow honorees will be officially recognized at the 2026 Health Care Champion Awards on March 19 and at the Titan 100 Awards on May 7.

News Contact

Laurie Haigh
Institute Communications

Feb. 02, 2026
Hannah Youngblood
Raquel Lieberman

An estimated 4 million Americans have glaucoma, a group of eye diseases that can lead to irreversible blindness. Now, Georgia Tech is home to a Glaucoma Research Fund that will support cutting-edge work to understand and advance treatments for the disease.

The new initiative was sparked by ongoing research at Georgia Tech — and a Yellow Jacket connection: when Postdoctoral Research Fellow Hannah Youngblood’s work on exfoliation glaucoma (XFG) was featured by the BrightFocus Foundation, it caught the attention of Jennifer Rucker, an Alabama resident who was diagnosed with XFG several years ago.

Excited that the research could change outcomes for people like her — and proud that it’s happening at her husband Philip Rucker’s, EE 72, alma mater — Jennifer Rucker reached out to Youngblood and her advisor, School of Chemistry and Biochemistry Professor and Kelly Sepcic Pfeil, Ph.D. Chair Raquel Lieberman

“As the wife of a Georgia Tech graduate and an individual with pseudoexfoliation glaucoma, I was inspired to support the scientists whose efforts may help me and others,” Jennifer Rucker says. What followed was a meaningful dialogue and a shared sense of purpose — and the creation of the Georgia Tech Glaucoma Research Fund (Wreck Glaucoma! Fund). 

“It meant so much that Jennifer took the initiative to reach out to learn more about our research,” says Lieberman. “Moments like this remind me how deeply meaningful it is to connect with people in the broader community who are navigating glaucoma. Opportunities for such personal connections are rare, but they inspire and further motivate us to achieve our lab’s mission to improve the lives of individuals suffering from blindness diseases.”

A Personal Connection

Youngblood’s interest in glaucoma research also stems from a personal connection: her father was diagnosed with glaucoma as a young adult. Now, Youngblood studies the genetic and molecular factors behind XFG in the Lieberman research lab

“XFG is an aggressive form of the disease with no known cure,” Youngblood says. While scientists know that XFG is the result of abnormal accumulation of proteins in the eye, current treatments only address symptoms rather than treating the root cause of the disease.

“We know XFG is driven by protein buildup, but we still don’t know why it happens,” she explains. “My work studying specific genetic variants aims to uncover this.” 

The Genetics of Glaucoma

In particular, Youngblood is researching the role of LOXL1, a protein that plays a role in soft tissue throughout the body, including the eyes.

“Research has shown that people with variants in the genes responsible for this protein are more likely to have XFG,” she says. “That made me curious to see if the variants might be impacting the structure of the LOXL1 protein itself and how those variants might lead to disease.”

Youngblood is currently testing her theory in the lab. “My hope is that new insight into proteins like LOXL1 will bring us closer to treatments that address XFG at its source,” she says. “The new Georgia Tech Glaucoma Research Fund is a tremendous step forward in making that hope a reality.”

Support the Georgia Tech Glaucoma Research Fund

Please visit the Glaucoma Research Fund support page to give to this specific program. To discuss additional philanthropic opportunities, please contact the College of Sciences Development Team: development@cos.gatech.edu

Your investment ensures that these scholars and researchers have world-class resources, facilities, and mentors to excel in this critical work. Thank you for helping us shape the future.

News Contact

Selena Langner

Jan. 29, 2026
A panel of five speakers sits on tall stools at the front of a classroom, participating in a moderated discussion. The moderator on the left holds papers while addressing the group. A large presentation slide behind the panel displays names and academic titles. Audience members are partially visible in the foreground, and tables, chairs, and a water bottle are arranged throughout the room.

Georgia Tech’s Institute for Matter and Systems (IMS) hosted its second Boundaries and Breakthroughs panel on Jan. 27, bringing together leading clinicians, engineers, and data experts to examine why promising medical technologies often fail to translate into clinical practice.

Moderated by IMS Executive Director Eric Vogel, the panel explored how innovation, regulation, economics and clinical realities intersect to shape the future of medical devices. 

The panel featured Jon Duke, physician and director of the Center for Health Analytics and Informatics at Georgia Tech Research Institute; Matthew Flavin, assistant professor in the School of Electrical and Computer Engineering; HyunJoo Oh, assistant professor in the schools of Industrial Design and Interactive Computing; and Lokesh Guglani, pediatric pulmonologist and clinician-researcher at Children’s Healthcare of Atlanta. 

Vogel opened the event by highlighting the gap between technological novelty and real-world medical adoption. 

“About 75% of medical device start-ups never achieve commercial success or make it to market, and some industry estimates push this higher,” Vogel said. “Even those that reach the market often fail to gain meaningful adoption. This may be because technologists optimize for platforms five or 10 years out and are rewarded by novelty, whereas clinicians demand reliability, interpretability, and outcomes that hold up with real patients, real workflows, and real liability.”

Throughout the discussion, panelists examined the balance between rapid innovation and clinical safety, noting that the level of invasiveness often determines how bold developers can be.

“We must remember that in medicine—and especially when we're dealing with human lives—there's a significant asymmetry of the harm that could be done,” said Guglani. “Even a small change or an oversight at the design level of a medical device can have significant downstream repercussions for patients and create liability for institutions and providers.”

Flavin and Duke added that excessive conservatism, particularly around non-invasive wearable, can also slow potentially life-changing advancements. 

All panelists agreed that breakthrough technology alone is not enough to ensure clinical adoption. Usability, workflow fit, and time efficiency often determine whether clinicians adopt a device. Tools that require lengthy calibration or add to a clinician’s already tight schedule rarely succeed. Even when a technology integrates well, reimbursement barriers can prevent adoption. 

 “A lot of technologies come out, but then if the clinic is using them and is not being reimbursed for the time spent, that creates a bottleneck,” said Guglani.

Economic constraints also shape who benefits from innovation. Children with rare diseases, stroke survivors, and other small or heterogeneous patient groups often struggle to attract investors, even when their needs are urgent.

The panelists also discussed the dual role of regulatory and manufacturing standards. Good Manufacturing Practice (GMP) requirements ensures consistent, safe production, but force teams to lock designs earlier than ideal, adding cost and slowing iteration. These requirements protect patients but also function as an economic filter for many early-stage technologies.

The conversation then turned to data, AI, and the education of future innovators. Despite massive amounts of health data, many clinically important areas remain data‑scarce. Wearable devices, such as smart watches, may help close these gaps, but AI models remain limited by the quality of input data. 

When asked about preparing the next generation of MedTech innovators, panelists emphasized the importance of “interface literacy” or the ability to collaborate across disciplinary boundaries and understand how design decisions cascade into real clinical environments.  

“You really do have to be able to be interdisciplinary,” said Duke. “Now of course what makes things go is not often the knowledge of the domain, but the person’s role or connectivity into the system.”

Vogel closed by emphasizing that successful medical technology development requires “ongoing, honest collaboration” across fields. The Boundaries and Breakthroughs series will continue that mission in February with a panel on the future of the electric grid.

News Contact

Amelia Neumeister | Communications Program Manager

The Institute for Matter and Systems

Jan. 28, 2026
During a research session, a participant looks at a monitor and imagines saying the text cue displayed on screen. Text below the cue shows the brain-computer interface’s prediction of her imagined words.

During a research session, a participant imagines saying the text cue on the screen. The bottom text is the brain-computer interface’s prediction of the imagined words. (Photo courtesy: Chethan Pandarinath)

Last summer, a team of researchers reported using a brain-computer interface to detect words people with paralysis imagined saying, even without them physically attempting to speak. They also found they could differentiate between the imagined words they wished to express and the person’s private inner thoughts.

It’s a significant step toward helping people with diseases like amyotrophic lateral sclerosis, or ALS, reconnect with language after they’ve lost the ability to talk. And it’s part of a long-running clinical trial on brain-computer interfaces involving biomedical engineers from Georgia Tech and Emory University alongside collaborators at Stanford University, Massachusetts General Hospital, Brown University, and the University of California, Davis. 

Together, they’re exploring how implanted devices can read brain signals and help patients use assistive devices to recover some of their lost abilities.

Speech has become one of the hottest areas for these interfaces as scientists leverage the power of artificial intelligence, according to Chethan Pandarinath, associate professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory and one of the researchers involved in the trials.

“We can place electrodes in parts of the brain that are related to speech,” he said, “and even if the person has lost the ability to talk, we can pick up the electrical activity as they try to speak and figure out what they’re trying to say.”

Read the full story in Helluva Engineer magazine.

News Contact

Joshua Stewart
College of Engineering

Nov. 19, 2025
Annabelle Singer

Annabelle Singer

Can flickering light and sound help fight Alzheimer’s disease? 

On this episode of Holy Shift!, host Angela Gill Nelms chats with Dr. Annabelle Singer from Georgia Tech and Emory University, whose groundbreaking research explores how carefully timed lights and sounds may help “tune” the brain, boost memory, and change the course of Alzheimer’s disease.  From building theater lights as a kid to decoding how brain waves shape memory, Dr. Singer is proving that sometimes the brightest ideas come from unexpected places.

Tune in to hear how groundbreaking science is lighting the way toward healthier brains and brighter futures.

News Contact

Kelly Petty

Jan. 16, 2026
A real worm in a Petri dish (top left) and a robot worm (bottom right) clean their environments of tiny particles in a very similar manner.

A real worm in a Petri dish (top left) and a robot worm (bottom right) clean their environments of tiny particles in a very similar manner.

When centimeter-long aquatic worms, such as T. tubifex or Lumbriculus variegatus, are placed in a Petri dish filled with sub-millimeter sized sand particles, something surprising happens. Over time, the worms begin to spontaneously clean up their surroundings. They sweep particles into compact clusters, gradually reshaping and organizing their environment.

In a study recently published in Physical Review X, a team of researchers show that this remarkable sweeping behavior does not require a brain, or any kind of complex interaction between the worms and the particles. Instead, it emerges from the natural undulating motion and flexibility that the worms possess.

The study was co-led by Saad Bhamla, associate professor in Georgia Tech’s School of Chemical and Biomolecular Engineering, and Antoine Deblais of the University of Amsterdam.

Deblais said: “It is fascinating to see how living worms can organize their surroundings just by moving.” Bhamla added: “Their activity and flexibility alone are enough to collect particles and reshape their environment.”

By building simple robotic and computer models that mimic the living worms, the researchers discovered that only these two ingredients – activity and flexibility – are sufficient to reproduce the sweeping and collecting effects. The result is a self-organized, dynamic form of environmental restructuring driven purely by motion and shape.

Order emerges

The results do not just teach us a surprising lesson about worms. Understanding how these organisms spontaneously collect particles has much broader implications. On the technological side, what the researchers have learned could inspire the design of soft robots that clean or sort materials without needing sensors or pre-programmed intelligence. 

Such robots, like the worms, would simply move and let order emerge from motion. “Brainless” machines of this sort could perhaps one day help remove microplastics or sediments from aquatic environments, or perform complex tasks in unpredictable terrains. 

From a biological perspective, the results also offer insights into how elongated living organisms – not just worms, but also filamentous bacteria, or cytoskeletal filaments – can structure and modify their own habitats through simple physical interactions. Understanding this structuring and modifying behaviour has been a central question for, e.g., earthworms in their role in soil aeration.

From a biological perspective, the results also offer insights into how elongated living organisms – not just worms, but also filamentous bacteria, or cytoskeletal filaments – can structure and modify their own habitats through simple physical interactions. Understanding this structuring and modifying behaviour has been a central question for, e.g., earthworms in their role in soil aeration.

Team effort

This project grew out of curiosity about how living systems shape their environment without centralized control. Initial experiments with worms, conducted by Harry Tuazon (Bioengineering PhD 2024) at Georgia Tech, showed the unexpected particle collection patterns. This led the team to attempt to reproduce the behavior using robotic and simulated counterparts – something that worked surprisingly well. In the project, experimentalists and theorists worked side by side, allowing the team to uncover the physical principles behind this seemingly purposeful behavior. 

Co-first author Rosa Sinaasappel conducted the robot experiments at the University of Amsterdam. “By mimicking the worms’ motion with simple brainless robots connected by flexible rubber links, we could pinpoint the two ingredients that are essential for the sweeping mechanism,” she said.

Co-first author Prathyusha Kokkoorakunnel Ramankutty, a research scientist in the Bhamla Lab at Georgia Tech, performed the computer simulations of the behavior. “Our computational model, built on simple ingredients like propulsion and flexibility, shows that this principle works across different scales and can be adapted for new designs, as demonstrated by a soft robotic sweeper that autonomously ‘cleans’ and reorganizes particles without programmed intelligence,” she explained.

The researchers will continue to investigate this type of behaviour in the future. While a mathematical model of active sweeping is now presented in a simple form, many challenging questions raised by this complex system remain open for theoreticians.

Multiple groups of students helped greatly with the robot experiments, doing projects in the lab. Their efforts ranged from performing the experiments to replacing the in total about 200 batteries, after perhaps one of the most difficult tasks: wrestling them free from the child-proof packaging.

CITATION:

Particle Sweeping and Collection by Active and Living Filaments, Sinaasappel, R., Prathyusha, K. R., Tuazon, Harry, Mirzahossein, E., Illien, P., Bhamla, Saad, and A. Deblais. Physical Review X (2026)

News Contact

Brad Dixon, braddixon@gatech.edu

Jan. 15, 2026
Community Engagement Graduate Fellows

Four graduate students from the College of Sciences were selected for the new Community Engagement Graduate Fellowship, made possible through a gift from Google.

C-PIES and Community Engagement Graduate Fellows

C-PIES Director Lewis A. Wheaton (far left) and Director of Programs Lea Marzo (far right) stand with the inaugural Community Engagement Graduate Fellows (left to right): Nikolai Simonov, Miriam Simma, Aniruddh Bakshi, and Katherine Slenker.

Four graduate students from the College of Sciences were recently selected for the new Community Engagement Graduate Fellowship, made possible through a gift from Google. This one-year research opportunity awards up to $5,000 for each fellow to develop a project with local partners that aims to build stronger communities. 

“It has been a pleasure for the Center for Programs to Increase Engagement in the Sciences (C-PIES) to collaborate with Google and the College of Sciences Advisory Board to bring this fellowship, which will positively impact our community and highlight how science can align with public good,” says Lewis A. Wheaton, professor in the School of Biological Sciences and director of C-PIES. 

In the year ahead, the fellows will work with C-PIES and community partners on campus and in the metro Atlanta area to develop projects in one of three priority areas: civic and policy engagement, community-engaged research, and K-12 research outreach. 

The fellowship was open to all graduate students in the College of Sciences, and four inaugural fellows — Aniruddh Bakshi, Katherine Slenker, Miriam Simma, and Nikolai Simonov — were named based on their exciting, yet feasible applications.

Fellow Aniruddh Bakshi: Strengthening trust in science 

Ph.D. student Aniruddh Bakshi studies the problem of drug delivery at the intersections of organic chemistry, biochemistry, and immunology. As mRNA vaccines are closely related to his area of research, he sees the need for a grassroots outreach movement from young academics to help bolster public confidence in rigorous scientific methodology. 

In collaboration with local hospitals and nonprofits, his proposed project is to start a social media content series, titled “A Day in the Life of a Ph.D. Student,” to show the realities of graduate school for those interested in this career path while connecting his research to broader public issues. 

“Science has the power to solve urgent problems, but only if people understand and trust it,” says Bakshi. “Through this fellowship, I will use my research and outreach efforts to help strengthen that trust — showing how discoveries in drug delivery and vaccine design can make a real difference in people’s lives.” 

Fellow Katherine Slenker: Creating a biodiversity data network 

Atlanta is often referred to as “the city in a forest,” but according to Ph.D. student Katherine Slenker, wildlife has a difficult time navigating across roads and housing developments, often resulting in human-wildlife conflict. 

“Conservation ecologists have long recommended that the movement of wildlife could be eased through the creation of ‘ecological corridors,’ which connect greenspaces and wildlife populations,” she explains. “Determining the movement patterns of wildlife, and where such corridors may be best situated, requires that we first understand what species reside in the metro Atlanta area as well as how they are expected to disperse.”

As a fellow, Slenker plans to build a biodiversity data network by comparing wildlife monitoring at Davidson-Arabia Mountain Nature Preserve and Stone Mountain Park and increasing the coalition of metro Atlanta researchers. This data can be used in the development of ecological corridors to reduce clashing between humans and wildlife, notably animals struck by vehicles, and improve ecosystem health at these parks. 

Fellow Miriam Simma: Making structural biology research more accessible 

The study of crystallography is vital in academia, industry, and medicine because it enables researchers to decipher the atomic structures of proteins, but it is scarcely taught outside of graduate school. Ph.D. student Miriam Simma wants to change that. 

Her proposed project is to introduce protein crystallography to K-12 students and teachers through hands-on activities in local high school classrooms and to the public during the Atlanta Science Festival at Georgia Tech.

“My vision is to make structural biology research accessible, so everyone can engage with cutting-edge scientific research — fostering curiosity and interest in STEM careers,” says Simma. “Long term, I will synthesize these activities into a chemical education article that introduces K-12 students to protein structure and function.” 

Fellow Nikolai Simonov: Mentoring middle school scientists 

Last year, Ph.D. student Nikolai Simonov became involved in the GoSTEM Club at Lilburn Middle School — leading student activities and recruiting other graduate student volunteers. In partnership with Georgia Tech’s Center for Education Integrating Science, Mathematics and Computing, the club is a weekly afterschool program for students, many of whom come from underserved backgrounds, to grow their scientific curiosity. 

“I assembled a team of 10 Tech graduate students who could explain complex scientific concepts in approachable ways for middle school students. Through this fellowship, we are excited to enrich the GoSTEM Club with an ongoing mentorship program and materials for more ambitious science fair projects,” shares Simonov. 

As part of the program, club members can meet one-on-one with Georgia Tech mentors to discuss their educational and career goals. “By sharing their stories and connecting scientific ideas to real-world applications, our mentors aim to show students that STEM is not only accessible but a path toward a fulfilling life,” he adds.

News Contact

Jess Hunt-Ralston
Director of Communications
College of Sciences at Georgia Tech

Writer: Annette Filliat

Jan. 12, 2026
Degraded marsh on Cumberland Island, Georgia.

Degraded marsh on Cumberland Island, Georgia.

Kostka sampling transects of marshland on Cumberland Island, Georgia.

Kostka sampling transects of marshland on Cumberland Island, Georgia.

Erosion around the historic property “Dungeness” on Cumberland Island, Georgia.

Erosion around the historic property “Dungeness” on Cumberland Island, Georgia.

Flooding in the town of St. Marys, a town in Camden County, Georgia.

Flooding in the town of St. Marys, a town in Camden County, Georgia.

The National Fish and Wildlife Foundation (NFWF) has awarded an interdisciplinary team nearly $1 million in funding through the National Coastal Resilience Fund to restore coastal wetlands in Georgia. It was the only project in Georgia to be selected for funding from the program's 2025 call for proposals.

The award will support the design of nature-based solutions including living shorelines and marsh restoration in flood-prone areas of Camden County, Georgia, adjacent to Naval Submarine Base Kings Bay, Cumberland Island National Seashore, and the city of St. Marys. 

“Restoring wetlands in Camden County is not just an environmental priority — it’s a resilience strategy for the entire region,” says principal investigator (PI) Joel Kostka, Tom and Marie Patton Distinguished Professor, associate chair for Research in the School of Biological Sciences, and faculty director of Georgia Tech for Georgia’s Tomorrow. “Each acre of restored marshland protects coastal communities from natural hazards like storms and flooding, provides essential marine habitat, and has the potential to aid the Navy and the Army Corps of Engineers in developing management alternatives for dredged materials. When our wetlands flourish, our whole coastline does.”

In addition to Kostka, co-PI’s include University of Georgia (UGA) Skidaway Institute of Oceanography Director Clark Alexander, UGA Associate Professor Matt Bilskie and Professor Brian BledsoeThe Nature Conservancy Coastal Climate Adaptation Director Ashby Worley, and Georgia Tech alumnus Nolan Williams of Robinson Design Engineers, a firm dedicated to the engineering of natural infrastructure in the Southeast that is owned and operated by Georgia Tech alumnus Joshua Robinson.

A coastal collaboration

The new project, known as a “pipeline project” by NFWF,  builds on multiple resilience plans and years of previous research conducted by the established team. “This is a testament to the value of the long-term collaborations and partnerships that enable coastal resilience work,” Kostka says. “We’re working closely with local communities and a range of city, state, and federal stakeholders to ensure these solutions align with local priorities and protect what matters most.”

It’s not the first time that the team has brought this type of collaboration to the coastline. Since 2019, Kostka has worked alongside the South Carolina Department of Natural Resources, the South Carolina Aquarium, and Robinson Design Engineers in a $2.6 million effort to restore degraded salt marshes in historic Charleston, also funded by NFWF. Now in the implementation phase, much of the marsh restoration in Charleston involves planting salt-tolerant grasses, restoring oyster reefs, and excavating new tidal creeks — work that is being spearheaded by local volunteers.

“Coastal resilience isn’t something one group can tackle alone,” Kostka adds. “That shared, community-driven vision is what makes these projects possible.”

News Contact

Written by Selena Langner

Subscribe to Bioengineering and Bioscience